Senthil Kumar Rajendran, Ph.D. is a Co-founder and board member of Anison Therapeutics. He is one of the key inventors behind the technology of Anison. He holds a Ph.D. in Medicinal Chemistry and has extensive research experience in drug development, with 15+ years, and published more than 26 peer-reviewed articles. During his career, he has been a key member of the product design and development for various Business Finland and Novo Nordisk funded projects.